Diamond Hill Capital Management, LLC (Investment Advisor)
Institutional investor · Portfolio as of Q1 2019
Top Holdings164 positions
Citigroup Inc | 10.2M | $633.7M | 3.5% | $48.26 | 0.00% | 1 qtr | First report 0 |
Abbott Laboratories | 7M | $557.6M | 3.1% | $69.76 | 0.00% | 1 qtr | First report 0 |
Alphabet Inc | 458,590 | $539.7M | 3.0% | $58.29 | 0.00% | 1 qtr | First report 0 |
MetLife Inc | 10.7M | $454.7M | 2.5% | $33.14 | 0.00% | 1 qtr | First report 0 |
Berkshire Hathaway Inc | 2.2M | $448.7M | 2.5% | $200.89 | 0.00% | 1 qtr | First report 0 |
VANTIV INC | 3.8M | $433M | 2.4% | — | — | 1 qtr | First report 0 |
Cimarex Energy Co | 6M | $418.3M | 2.3% | — | — | 1 qtr | First report 0 |
Microsoft Corp | 3.5M | $407.1M | 2.2% | $110.12 | 0.00% | 1 qtr | First report 0 |
| 3M | $391.7M | 2.2% | — | — | 1 qtr | First report 0 | |
BorgWarner Inc | 9.9M | $381.9M | 2.1% | $30.41 | 0.00% | 1 qtr | First report 0 |
American International Group I | 8.8M | $380.1M | 2.1% | $35.50 | 0.00% | 1 qtr | First report 0 |
Discover Financial Services | 5.3M | $374.2M | 2.1% | — | — | 1 qtr | First report 0 |
TJX Cos Inc/The | 6.9M | $368.3M | 2.0% | $48.16 | 0.00% | 1 qtr | First report 0 |
Medtronic PLC | 3.9M | $356.2M | 2.0% | $73.57 | 0.00% | 1 qtr | First report 0 |
Facebook Inc | 2.1M | $349.3M | 1.9% | $165.11 | 0.00% | 1 qtr | First report 0 |
Pfizer Inc | 7.6M | $322.3M | 1.8% | $28.06 | 0.00% | 1 qtr | First report 0 |
Walt Disney Co/The | 2.8M | $308.3M | 1.7% | $106.35 | 0.00% | 1 qtr | First report 0 |
Philip Morris International In | 3.5M | $305.3M | 1.7% | $62.25 | 0.00% | 1 qtr | First report 0 |
NVR Inc | 107,241 | $296.7M | 1.6% | $2,767.00 | 0.00% | 1 qtr | First report 0 |
United Continental Holdings In | 3.7M | $291.9M | 1.6% | $79.78 | 0.00% | 1 qtr | First report 0 |
Diamond Hill Capital Management, LLC (Investment Advisor) manages $18.2B across 164 positions as of Q1 2019. Top holdings: C (3.5%), ABT (3.1%), GOOGL (3.0%). Fund DNA: Steady Compounder. HoldingsIntel Score: 2.5/5.0.
First quarter we have for this fund: 164 positions, nothing earlier to compare. No standout high-conviction moves this quarter. Portfolio: $18.2B across 164 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR